Even UEFA seems to realize this bsky.app/profile/apvo...
I thought UEFA would just comment on the red card thing, not on US politics and SCOTUS...😲
"When the certainty of rules is no longer guaranteed by its guardians, the integrity of the game is at stake and the credibility of a competition is undermined."
www.uefa.com/news-media/n...
"When the certainty of rules is no longer guaranteed by its guardians, the integrity of the game is at stake and the credibility of a competition is undermined."
www.uefa.com/news-media/n...
UEFA statement on the Balogun case
Statement on decision related to Folarin Balogun
www.uefa.com
July 7, 2026 at 6:24 AM
Even UEFA seems to realize this bsky.app/profile/apvo...
🚨 $APVO
On September 24, 2026, Aptevo Therapeutics Inc. issued a press release announcing progress in its next-generation trispecific programs.
On September 24, 2026, Aptevo Therapeutics Inc. issued a press release announcing progress in its next-generation trispecific programs.
SEC Filing: APVO
Click to view the official SEC document.
www.sec.gov
September 24, 2026 at 12:59 PM
🚨 $APVO
On September 24, 2026, Aptevo Therapeutics Inc. issued a press release announcing progress in its next-generation trispecific programs.
On September 24, 2026, Aptevo Therapeutics Inc. issued a press release announcing progress in its next-generation trispecific programs.
🚨 $APVO
On September 22, 2026, Aptevo Therapeutics Inc. held its Special Meeting of Stockholders , at which a quorum was present.
On September 22, 2026, Aptevo Therapeutics Inc. held its Special Meeting of Stockholders , at which a quorum was present.
SEC Filing: APVO
Click to view the official SEC document.
www.sec.gov
September 23, 2026 at 8:45 PM
🚨 $APVO
On September 22, 2026, Aptevo Therapeutics Inc. held its Special Meeting of Stockholders , at which a quorum was present.
On September 22, 2026, Aptevo Therapeutics Inc. held its Special Meeting of Stockholders , at which a quorum was present.
Pretend to commute to work
#7syllablesquad #pretend
#7syllablesentence
Good morning, môge, Moin! A beautiful Monday morning seduced me to take the long way to work. May you be seduced by beauty today as well - strictly in a good and platonic way of course 😁
#7syllablesquad #pretend
#7syllablesentence
Good morning, môge, Moin! A beautiful Monday morning seduced me to take the long way to work. May you be seduced by beauty today as well - strictly in a good and platonic way of course 😁
August 24, 2026 at 9:24 AM
#APVO Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development
https://www.stocktitan.net/news/APVO/aptevo-advances-next-generation-trispecific-candidate-toward-oaz6pa1if7wb.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/APVO/aptevo-advances-next-generation-trispecific-candidate-toward-oaz6pa1if7wb.html?utm_source=stocktitan-bluesky&utm_medium=social
Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development
Aptevo Therapeutics (APVO) is optimizing trispecific cancer-drug candidates for scalable manufacturing and expects APVO451 to enter IND-enabling studies in 1H2027.The manufacturing work is intended to make the candidates reliably and consistently before human testing. Investigational New Drug (IND)-enabling studies are preparatory steps before that testing. The trispecific approach aims to combine three functions in one molecule: recognizing cancer, activating an immune response and helping overcome cancer defenses. Aptevo says its manufacturing capabilities may also support additional candidates from its ADAPTIR-FLEX platform.
www.stocktitan.net
September 24, 2026 at 12:05 PM
#APVO Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development
https://www.stocktitan.net/news/APVO/aptevo-advances-next-generation-trispecific-candidate-toward-oaz6pa1if7wb.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/APVO/aptevo-advances-next-generation-trispecific-candidate-toward-oaz6pa1if7wb.html?utm_source=stocktitan-bluesky&utm_medium=social
Australian Anti-Trans Activist Kirralie Smith Loses AVO Appeal Against Trans Soccer Player
Smith tweeted to nearly 40,000 followers calling for “men from the Mid North Coast” to assist with “the bloke playing on the women’s team in Wingham.
www.starobserver.com.au/news/anti-tr...
Smith tweeted to nearly 40,000 followers calling for “men from the Mid North Coast” to assist with “the bloke playing on the women’s team in Wingham.
www.starobserver.com.au/news/anti-tr...
Anti-Trans Activist Kirralie Smith Loses AVO Appeal Against Transgender Soccer Player - Star Observer
The NSW Court of Appeal has upheld a two-year (APVO) protecting a transgender soccer player, from anti-trans activist Kirralie Smith.
www.starobserver.com.au
August 16, 2025 at 2:57 AM
Australian Anti-Trans Activist Kirralie Smith Loses AVO Appeal Against Trans Soccer Player
Smith tweeted to nearly 40,000 followers calling for “men from the Mid North Coast” to assist with “the bloke playing on the women’s team in Wingham.
www.starobserver.com.au/news/anti-tr...
Smith tweeted to nearly 40,000 followers calling for “men from the Mid North Coast” to assist with “the bloke playing on the women’s team in Wingham.
www.starobserver.com.au/news/anti-tr...
Slight conflict on the Kirralie Smith AVO: previous coverage said her appeal against the AVO had been dismissed by the Supreme Court, whereas this says it's been dismissed by the Court of Appeal. lsj.com.au/articles/cou...
Court dismisses appeal by anti-trans activist - Law Society Journal
NSW Court of Appeal upholds APVO against anti-trans activist Kirralee Smith, affirming that online harassment, even presented as political speech, can justify legal protection.
lsj.com.au
August 19, 2025 at 9:18 AM
Slight conflict on the Kirralie Smith AVO: previous coverage said her appeal against the AVO had been dismissed by the Supreme Court, whereas this says it's been dismissed by the Court of Appeal. lsj.com.au/articles/cou...
$APVO — Other Company Update
Aptevo Therapeutics announced progress in its next-generation trispecific programs, focusing on optimizing candidates for scalable manufacturing ahead of future human testing. The lead candidate, APVO451, is expected to enter IND-enabling studies in 1H...
🧵 continued ↓
Aptevo Therapeutics announced progress in its next-generation trispecific programs, focusing on optimizing candidates for scalable manufacturing ahead of future human testing. The lead candidate, APVO451, is expected to enter IND-enabling studies in 1H...
🧵 continued ↓
September 24, 2026 at 7:17 PM
$APVO — Other Company Update
Aptevo Therapeutics announced progress in its next-generation trispecific programs, focusing on optimizing candidates for scalable manufacturing ahead of future human testing. The lead candidate, APVO451, is expected to enter IND-enabling studies in 1H...
🧵 continued ↓
Aptevo Therapeutics announced progress in its next-generation trispecific programs, focusing on optimizing candidates for scalable manufacturing ahead of future human testing. The lead candidate, APVO451, is expected to enter IND-enabling studies in 1H...
🧵 continued ↓
Second Life: Mobile User Group meeting (27 March 2025)
YouTube video by Pantera Północy
www.youtube.com
March 27, 2025 at 7:54 PM
JUST IN: ( NASDAQ: #APVO ) Aptevo Therapeutics Reports 3Q 2024 Financial Results and Provides a Business Update
#StockMarket #News
#StockMarket #News
November 7, 2024 at 7:00 PM
We just added a new article! - Star Observer - Anti-Trans Activist Kirralie Smith Loses AVO Appeal Against Transgender Soccer Player
trans.au/star-observe...
trans.au/star-observe...
Anti-Trans Activist Kirralie Smith Loses AVO Appeal Against Transgender Soccer Player - Star Observer
The NSW Court of Appeal has upheld a two-year (APVO) protecting a transgender soccer player, from anti-trans activist Kirralie Smith.
trans.au
August 16, 2025 at 7:00 AM
We just added a new article! - Star Observer - Anti-Trans Activist Kirralie Smith Loses AVO Appeal Against Transgender Soccer Player
trans.au/star-observe...
trans.au/star-observe...
BREAKING NEWS: ( NASDAQ: #APVO ) US Companies Moving the Markets, Morning edition <br>Tue, Oct 22, 2024 as of 10.00 am ET
#StockMarket #News
#StockMarket #News
October 22, 2024 at 2:15 PM
BREAKING NEWS: ( NASDAQ: #APVO ) US Companies Moving the Markets, Morning edition <br>Tue, Oct 22, 2024 as of 10.00 am ET
#StockMarket #News
#StockMarket #News
Breaking News: ( NASDAQ: #APVO ) Bispecific Antibody, APVO442, Differentiated to Treat Prostate Cancer with Precision Tumor Targeting and Reduced Risk of Side Effects
#StockMarket #News
#StockMarket #News
December 4, 2024 at 6:55 PM
www.youtube.com/watch?v=aPvO... LOVE THIS CASE! Smartish iPhone 15 Plus Magnetic Case - Gripmunk Compatible with MagSafe
LOVE THIS CASE! Smartish iPhone 15 Plus Magnetic Case - Gripmunk Compatible with MagSafe
YouTube video by Robert Veach
www.youtube.com
March 26, 2026 at 11:10 PM
www.youtube.com/watch?v=aPvO... LOVE THIS CASE! Smartish iPhone 15 Plus Magnetic Case - Gripmunk Compatible with MagSafe
Feel free to walk away mid-post, but I just stumbled on your post and see that you actually exist. I was talking about you the other day...
bsky.app/profile/apvo...
bsky.app/profile/apvo...
Newsflash: I just updated my profile to confess that I'm a catless cat lover. There may be childless cat ladies according to someone who will not be named. And there are catless cat lovers that have particular reasons to be catless, for example prioritization of human-human over human-cat relations.
July 11, 2026 at 9:37 AM
Feel free to walk away mid-post, but I just stumbled on your post and see that you actually exist. I was talking about you the other day...
bsky.app/profile/apvo...
bsky.app/profile/apvo...
#APVO Aptevo Provides State of the Business Report and 2025 Financial Results
https://www.stocktitan.net/news/APVO/aptevo-provides-state-of-the-business-report-and-2025-financial-40grwal15joy.html
https://www.stocktitan.net/news/APVO/aptevo-provides-state-of-the-business-report-and-2025-financial-40grwal15joy.html
Aptevo Provides State of the Business Report and 2025 Financial Results
Latest mipletamig data delivers 86% clinical benefit rate with no cytokine release syndrome in 28 frontline AML patients, supporting its potential to enhance standard-of-care combination therapyCompany expands CD3 pipeline and introduces first trispecific drug candidatesSEATTLE, WA / ACCESS
www.stocktitan.net
March 26, 2026 at 12:05 PM
#APVO Aptevo Provides State of the Business Report and 2025 Financial Results
https://www.stocktitan.net/news/APVO/aptevo-provides-state-of-the-business-report-and-2025-financial-40grwal15joy.html
https://www.stocktitan.net/news/APVO/aptevo-provides-state-of-the-business-report-and-2025-financial-40grwal15joy.html
Belated good morning / good afternoon! I hope you don't mind me adding this below your post - but the similarity in images just struck me. My image is from Lelystad, the Netherlands
bsky.app/profile/apvo...
bsky.app/profile/apvo...
It takes but a single spark
Good morning, môge, Moin. May a bright spark ignite your day.
#7syllablesentence #spark
Good morning, môge, Moin. May a bright spark ignite your day.
#7syllablesentence #spark
July 8, 2026 at 12:39 PM
Belated good morning / good afternoon! I hope you don't mind me adding this below your post - but the similarity in images just struck me. My image is from Lelystad, the Netherlands
bsky.app/profile/apvo...
bsky.app/profile/apvo...
#APVO Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML
https://www.stocktitan.net/news/APVO/mipletamig-delivers-100-remission-rate-in-cohort-3-of-rainier-trial-txeizkaa0ei2.html
https://www.stocktitan.net/news/APVO/mipletamig-delivers-100-remission-rate-in-cohort-3-of-rainier-trial-txeizkaa0ei2.html
100% Remission Rate: Aptevo's Novel AML Drug Shows Perfect Response in Latest Trial Cohort, Zero Toxicity
Mipletamig achieves 100% remission in Cohort 3 of RAINIER trial for frontline AML, with 40% MRD-negative status. No dose-limiting toxicities observed. Cohort 4 now enrolling.
www.stocktitan.net
September 16, 2025 at 12:30 PM
#APVO Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML
https://www.stocktitan.net/news/APVO/mipletamig-delivers-100-remission-rate-in-cohort-3-of-rainier-trial-txeizkaa0ei2.html
https://www.stocktitan.net/news/APVO/mipletamig-delivers-100-remission-rate-in-cohort-3-of-rainier-trial-txeizkaa0ei2.html
Watchlist for today 👇
🔗 Full analysis here: x.com/usstockpros?...
$AQB | $APVO | $ATCH | $NBTX
#stocks 💹 | #investing 💰 | #stockmarket 📉 | #الأسهم_الأمريكية 📈
🔗 Full analysis here: x.com/usstockpros?...
$AQB | $APVO | $ATCH | $NBTX
#stocks 💹 | #investing 💰 | #stockmarket 📉 | #الأسهم_الأمريكية 📈
us stock pros (@usstockpros) / X
us stock pros (@usstockpros) / X
x.com
September 18, 2025 at 3:46 AM
Watchlist for today 👇
🔗 Full analysis here: x.com/usstockpros?...
$AQB | $APVO | $ATCH | $NBTX
#stocks 💹 | #investing 💰 | #stockmarket 📉 | #الأسهم_الأمريكية 📈
🔗 Full analysis here: x.com/usstockpros?...
$AQB | $APVO | $ATCH | $NBTX
#stocks 💹 | #investing 💰 | #stockmarket 📉 | #الأسهم_الأمريكية 📈
"In August, Smith lost her appeal in the New South Wales Supreme Court against a decision to put in place an apprehended personal violence order (APVO) to protect one of the players from further harassment and intimidation."
December 6, 2025 at 3:37 AM
"In August, Smith lost her appeal in the New South Wales Supreme Court against a decision to put in place an apprehended personal violence order (APVO) to protect one of the players from further harassment and intimidation."
$APVO Aptevo Highlights the Potential of the Company's Robust Portfolio in Cancer Immunotherapy, the Success of Bispecifics as a Category, and Their Growing Importance in the Oncology Treatment Paradigm
November 22, 2024 at 1:37 PM
$APVO Aptevo Highlights the Potential of the Company's Robust Portfolio in Cancer Immunotherapy, the Success of Bispecifics as a Category, and Their Growing Importance in the Oncology Treatment Paradigm
BREAKING NEWS: ( NASDAQ: #APVO ) Aptevo Therapeutics and Alligator Bioscience to Present Additional Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at SITC 2024
#StockMarket #News
#StockMarket #News
October 29, 2024 at 5:30 PM